CA2098729A1 - Azabicyclic amides or esters of halogenated benzoic acids - Google Patents

Azabicyclic amides or esters of halogenated benzoic acids

Info

Publication number
CA2098729A1
CA2098729A1 CA002098729A CA2098729A CA2098729A1 CA 2098729 A1 CA2098729 A1 CA 2098729A1 CA 002098729 A CA002098729 A CA 002098729A CA 2098729 A CA2098729 A CA 2098729A CA 2098729 A1 CA2098729 A1 CA 2098729A1
Authority
CA
Canada
Prior art keywords
compound according
compound
formula
chloro
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002098729A
Other languages
English (en)
French (fr)
Inventor
Francis D. King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2098729A1 publication Critical patent/CA2098729A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002098729A 1990-12-19 1991-12-12 Azabicyclic amides or esters of halogenated benzoic acids Abandoned CA2098729A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909027487A GB9027487D0 (en) 1990-12-19 1990-12-19 Pharmaceuticals
GB9027487.9 1990-12-19

Publications (1)

Publication Number Publication Date
CA2098729A1 true CA2098729A1 (en) 1992-06-20

Family

ID=10687217

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002098729A Abandoned CA2098729A1 (en) 1990-12-19 1991-12-12 Azabicyclic amides or esters of halogenated benzoic acids

Country Status (13)

Country Link
EP (1) EP0563087A1 (enExample)
JP (1) JPH06503332A (enExample)
KR (1) KR930703308A (enExample)
AU (1) AU9053391A (enExample)
CA (1) CA2098729A1 (enExample)
GB (1) GB9027487D0 (enExample)
IE (1) IE914395A1 (enExample)
MX (1) MX9102630A (enExample)
NZ (1) NZ241019A (enExample)
PT (1) PT99831A (enExample)
TW (1) TW226020B (enExample)
WO (1) WO1992011259A1 (enExample)
ZA (1) ZA919884B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
GB9721139D0 (en) 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
AU2001282874A1 (en) * 2000-08-18 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
AU2001284645A1 (en) * 2000-08-18 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
US6486172B2 (en) 2000-08-18 2002-11-26 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
US6492385B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6599916B2 (en) 2000-08-21 2003-07-29 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
WO2002017358A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
PE20021019A1 (es) 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
MXPA04007936A (es) 2002-02-15 2004-11-26 Upjohn Co Compuestos de aril-sustituidos para el tratamiento de enfermedades.
US7176198B2 (en) 2002-08-01 2007-02-13 Pfizer Inc. 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease
TW200842733A (en) 2007-04-17 2008-11-01 Univ Nat Chiao Tung Object image detection method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2476088A2 (fr) * 1979-01-16 1981-08-21 Delalande Sa Nouveaux derives du nor-tropane, leur procede de preparation et leur application en therapeutique
FR2529548A1 (fr) * 1982-07-02 1984-01-06 Delalande Sa Nouveaux derives de l'amino-3 quinuclidine, leur procede et leur application en therapeutique
EP0220011A3 (en) * 1985-10-12 1990-01-03 Beecham Group Plc Use of azabicloalkylbenzamides in the treatment of gastrointestinal motility disorders, migraine, emesis, cluster headaches, trigeminal neuralgia and arrhythmia
GB8829079D0 (en) * 1988-12-13 1989-01-25 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
NZ241019A (en) 1994-07-26
PT99831A (pt) 1992-12-31
GB9027487D0 (en) 1991-02-06
ZA919884B (en) 1992-10-28
AU9053391A (en) 1992-07-22
EP0563087A1 (en) 1993-10-06
TW226020B (enExample) 1994-07-01
MX9102630A (es) 1992-06-01
IE914395A1 (en) 1992-07-01
WO1992011259A1 (en) 1992-07-09
KR930703308A (ko) 1993-11-29
JPH06503332A (ja) 1994-04-14

Similar Documents

Publication Publication Date Title
EP0255297B1 (en) Azabicyclic compounds, process for their preparation, and their pharmaceutical use
US4937247A (en) 1-acyl indazoles
IE911399A1 (en) Novel compounds
IE58313B1 (en) Azabicyclononyl-indazole-carboxamide having 5-ht antagonist activity
IE60111B1 (en) Indole derivatives having an azabicyclic side chain, process for their preparation, intermediates, and pharmaceutical compositions
EP0315390A2 (en) Novel 4-oxobenzotriazines and 4-oxoquinazolines
EP0377967A2 (en) 9-Aza-3-(oxa/thia)-bicyclo[3,2,1]nonane derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
JP2643274B2 (ja) イミダゾ〔１，２−ａ〕ピリジン誘導体
EP0254584A2 (en) Azabicyclic compounds, process for their preparation, and their pharmaceutical use
CA2098729A1 (en) Azabicyclic amides or esters of halogenated benzoic acids
EP0289170A2 (en) Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
AU652187B2 (en) 3,9-diazabicyclo (3.3.1) nonan-7-YL derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
EP0261964A2 (en) Azabicyclic compounds and their use as 5-ht3 receptor antagonists
US5726187A (en) N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists
WO1993008185A1 (en) N-aryl-n1-azabicyclo-ureas as 5-ht3 antagonists
CZ391291A3 (en) Defined 2,3-dihydro-indole-1-carboxamido-n-(8-azabicyclo (3.2.1) -octan-3-yl) derivatives, exhibiting 5-ht-antagonists activity
IE914315A1 (en) Pharmaceuticals
WO1991001316A1 (en) New 9-azabicyclo[3.3.1]nonane-derivate
EP0611370A1 (en) Pyridine-3-carboxylic acid esters or amides useful as 5-ht 3? antagonists
HK1012356B (en) 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FZDE Dead